IZERVAY Market Poised for Remarkable Growth Through 2034 Fueled by Geographic Atrophy Treatment Breakthroughs
The market for IZERVAY (avacincaptad pegol), a recently approved therapy for geographic atrophy (GA) secondary to age-related macular degeneration (AMD),...
